Nakai Tokiko, Sakurada Akihisa, Endo Toshihide, Kobayashi Hiroko, Masuda Shinobu, Makishima Makoto, Esumi Mariko
Division of Oncologic Pathology, Department of Pathology and Microbiology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara 634-8521, Japan.
Oncol Lett. 2019 Feb;17(2):1883-1888. doi: 10.3892/ol.2018.9809. Epub 2018 Dec 7.
The mitochondrial DNA (mtDNA) displacement loop (D-loop) is often altered in various cancer types, including with regard to simple sequence repeat number variation (SSRNV), which includes the C-tract and CA-tract. However, because of mitochondrial heteroplasmy and slippage errors by the Taq DNA polymerase used in polymerase chain reaction (PCR) analysis, it is difficult to precisely evaluate mtDNA D-loop SSRNV experimentally. In this study, to precisely determine cancer-specific variants in mtDNA SSRNV, various microscopic portions of cancerous tissues and normal control tissues were obtained from a patient with breast cancer, followed by laser-capture microdissection of formalin-fixed paraffin-embedded specimens. Regions containing (CA) repeats (positions 514-523) and (C) repeats (positions 303-315) of the mitochondria DNA D-loop were amplified and sequenced. Variant signals of mtDNA SSRs of (CA) and (C) were observed in normal and cancerous tissues, with the content of minor alleles (CA) and (C)/(C) differing among samples. These results were confirmed by PCR using various primers and proofreading DNA polymerases. PCR of genomic SSRs of (CA) in the gene and (C) in the gene showed a simple repeat in all samples that was different from the observed mtDNA SSRNV. The present study suggests a reliable procedure for determining cancer-specific variants in mtDNA SSRNV: Using a proofreading DNA polymerase for PCR, the background of slippage by PCR is determined by PCR of the same genomic sequence as the target. Due to the varied heteroplasmy level of mtDNA SSRNV among normal tissues, the second background of polymorphic variations should be determined by several normal tissue DNA as PCR templates. Finally, the cancer-specific variant, including its variation frequency, is determined by subtracting the two background signals from the variant signals in cancer. However, care must be taken, as normal heteroplasmy drifts observed in mtDNA SSRNV may complicate such estimations.
线粒体DNA(mtDNA)置换环(D环)在包括简单序列重复数变异(SSRNV)在内的各种癌症类型中常常发生改变,SSRNV包括C序列和CA序列。然而,由于线粒体异质性以及聚合酶链反应(PCR)分析中使用的Taq DNA聚合酶的滑动错误,很难通过实验精确评估mtDNA D环SSRNV。在本研究中,为了精确确定mtDNA SSRNV中的癌症特异性变异,从一名乳腺癌患者身上获取了癌组织和正常对照组织的各个微观部分,随后对福尔马林固定石蜡包埋标本进行激光捕获显微切割。对线粒体DNA D环中包含(CA)重复序列(位置514 - 523)和(C)重复序列(位置303 - 315)的区域进行扩增和测序。在正常组织和癌组织中均观察到(CA)和(C)的mtDNA SSRs变异信号,不同样本中的次要等位基因(CA)和(C)/(C)含量有所不同。使用各种引物和校对DNA聚合酶进行PCR,证实了这些结果。对基因中(CA)和基因中(C)的基因组SSRs进行PCR,结果显示所有样本中的简单重复与观察到的mtDNA SSRNV不同。本研究提出了一种确定mtDNA SSRNV中癌症特异性变异的可靠方法:在PCR中使用校对DNA聚合酶,通过与靶标相同基因组序列的PCR来确定PCR滑动的背景。由于正常组织中mtDNA SSRNV的异质性水平各不相同,应使用多个正常组织DNA作为PCR模板来确定多态性变异的第二个背景。最后,通过从癌症中的变异信号中减去两个背景信号来确定癌症特异性变异,包括其变异频率。然而,必须注意的是,mtDNA SSRNV中观察到的正常异质性漂移可能会使此类估计变得复杂。